Lexeo Therapeutics, Inc. (LXEO)
4.07
-0.13
(-3.10%)
USD |
NASDAQ |
Sep 21, 16:00
4.07
0.00 (0.00%)
After-Hours: 20:00
Lexeo Therapeutics Market Cap : 319.99M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 330.21M |
| September 17, 2026 | 328.64M |
| September 16, 2026 | 327.07M |
| September 15, 2026 | 324.71M |
| September 14, 2026 | 331.00M |
| September 11, 2026 | 334.15M |
| September 10, 2026 | 342.79M |
| September 09, 2026 | 352.23M |
| September 08, 2026 | 374.24M |
| September 04, 2026 | 384.46M |
| September 03, 2026 | 380.53M |
| September 02, 2026 | 375.82M |
| September 01, 2026 | 369.53M |
| August 31, 2026 | 374.24M |
| August 28, 2026 | 382.11M |
| August 27, 2026 | 392.33M |
| August 26, 2026 | 393.90M |
| August 25, 2026 | 403.33M |
| August 24, 2026 | 386.82M |
| August 21, 2026 | 383.68M |
| August 20, 2026 | 397.83M |
| August 19, 2026 | 422.20M |
| August 18, 2026 | 387.61M |
| August 17, 2026 | 391.54M |
| August 14, 2026 | 380.53M |
| Date | Value |
|---|---|
| August 13, 2026 | 389.97M |
| August 12, 2026 | 382.89M |
| August 11, 2026 | 375.82M |
| August 10, 2026 | 364.02M |
| August 07, 2026 | 378.17M |
| August 06, 2026 | 337.09M |
| August 05, 2026 | 329.69M |
| August 04, 2026 | 326.72M |
| August 03, 2026 | 311.16M |
| July 31, 2026 | 305.98M |
| July 30, 2026 | 322.28M |
| July 29, 2026 | 319.31M |
| July 28, 2026 | 325.24M |
| July 27, 2026 | 331.17M |
| July 24, 2026 | 345.24M |
| July 23, 2026 | 348.95M |
| July 22, 2026 | 360.80M |
| July 21, 2026 | 345.24M |
| July 20, 2026 | 337.09M |
| July 17, 2026 | 347.47M |
| July 16, 2026 | 337.84M |
| July 15, 2026 | 351.17M |
| July 14, 2026 | 342.28M |
| July 13, 2026 | 344.13M |
| July 10, 2026 | 357.10M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 9.710B |
| Oncolytics Biotech, Inc. | 95.71M |
| Sangamo Therapeutics, Inc. | 60.03M |
| Sarepta Therapeutics, Inc. | 2.126B |
| Anixa Biosciences, Inc. | 93.38M |
Market Cap Related Metrics
| Price to Book Value | 1.361 |
| Price | 4.07 |
| Earnings Yield | -28.44% |